Rheumatoid Arthritis and Proteus (Record no. 100295)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03673nam a22004095i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-0-85729-950-5 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20140220083229.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 111003s2012 xxk| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780857299505 |
| -- | 978-0-85729-950-5 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-0-85729-950-5 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC927-927.5 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MJM |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED083000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.723 |
| Edition number | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Ebringer, Alan. |
| Relator term | author. |
| 245 10 - TITLE STATEMENT | |
| Title | Rheumatoid Arthritis and Proteus |
| Medium | [electronic resource] / |
| Statement of responsibility, etc | by Alan Ebringer. |
| 264 #1 - | |
| -- | London : |
| -- | Springer London, |
| -- | 2012. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | X, 233p. 53 illus., 2 illus. in color. |
| Other physical details | online resource. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Scope and Distribution of the RA Problem -- History of the Attempts to Find the Cause of RA -- HLA-DR1/4 and Antibodies to Proteus in London -- Antibodies to Proteus in Irish patients with rheumatoid arthritis -- Antibodies to Proteus in rheumatoid arthritis patients from Bermuda and from Hertfordshire in England -- Antibodies to Proteus in rheumatoid arthritis patients from Brest and Toulouse in France -- Dutch patients with rheumatoid arthritis have antibodies to Proteus -- Anti-Proteus antibodies in Norwegian rheumatoid arthritis patients following a lactovegetarian diet -- Antibodies to Proteus in rheumatoid arthritis patients from Norway, Spain and England -- Antibodies to Proteus in rheumatoid arthritis patients from southern Japan -- Urine Cultures and Correlation -- Molecular similarity between the “shared epitope” of rheumatoid arthritis and bacteria -- The “shared epitope”, Proteus haemolysin, XI collagen and rheumatoid arthritis -- Gram-negative bacteria possess sequences which resemble the “shared epitope”but only Proteus infect rheumatoid arthritis patients -- Immune responses to Proteus in rheumatoid arthritis patients from Finland and Japan -- Molecular similarity between the rheumatoid arthritis associated motif EQKRAA and structurally related sequences of Proteus -- Rheumatoid arthritis sera are cytotoxic to cells bearing HLA and collagen susceptibility sequences -- The scientific method of Sir Karl Popper. Rheumatoid arthritis and “Popper sequences”. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Rheumatoid Arthritis and Proteus explores the idea that Rheumatoid arthritis is caused by a urinary tract infection as a result of Proteus bacteria. Rheumatoid arthritis is a severe, painful and crippling disease affecting millions of people throughout the world, especially women. Genetic studies over the last 30 years have shown that individuals who possess the white cell blood groups HLA-DR1/4 carry a susceptibility sequence and are more likely to develop the disease. This book uses the methods of Sir Karl Popper, the philosopher of science, to present 12 “Popper sequences” which have been identified to indicate that Proteus is the causative agent of Rheumatoid Arthritis. Rheumatoid Arthritis and Proteus proposes that Anti-Proteus therapies should be followed as early as possible to prevent the crippling and irreversible joint deformities that occur in Rheumatoid Arthritis. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Rheumatology. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine & Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Rheumatology. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9780857299499 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://dx.doi.org/10.1007/978-0-85729-950-5 |
| 912 ## - | |
| -- | ZDB-2-SME |
No items available.